Pricing and dosage strategy Copy link to section Novo Nordisk has officially launched Ozempic in India, marking a significant expansion of its presence in one of the world's fastest-growing markets for diabetes and obesity treatments. The launch comes at a time when demand for weight-loss drugs is rising sharply, driven by lifestyle changes, urbanisation, and increasing awareness of metabolic health. India already has the second-highest number of people with type 2 diabetes globally, after China, alongside ...